Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: Past, present, and future

Steven Naymagon, Thomas A. Ullman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The evidence supporting the practice of dysplasia surveillance in inflammatory bowel disease (IBD) has remained sparse, and optimal detection strategies are still lacking. These issues, added to the declining incidence of dysplasia in IBD, have led to much debate over the diagnosis and management of dysplasia. White-light endoscopy with targeted and random biopsies remains the technique of choice for most practicing gastroenterologists. However, during the past decade, a surge of literature has questioned the efficacy of this strategy. Simultaneously, chromoendoscopy has emerged as an alternative, and perhaps superior, technique that has been included in some society guidelines. Nevertheless, many issues remain unclear, such as the best way to implement chromoendoscopy into everyday practice, whether there are any outcome benefits that can be attributed to the use of chromoendoscopy, and, perhaps most importantly, how to manage dysplasia uncovered by this and other advanced techniques. In this article, we discuss the various techniques currently available for dysplasia surveillance in IBD, with a focus on chromoendoscopy. Additionally, we highlight the overarching issues of setting appropriate endpoints and individualizing the care of patients with long-standing colitis.

Original languageEnglish (US)
Pages (from-to)304-311
Number of pages8
JournalGastroenterology and Hepatology
Volume11
Issue number5
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Colitis
Endoscopy
Patient Care
Guidelines
Biopsy
Light
Incidence

Keywords

  • Chromoendoscopy
  • Crohn's disease
  • Dysplasia
  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease : Past, present, and future. / Naymagon, Steven; Ullman, Thomas A.

In: Gastroenterology and Hepatology, Vol. 11, No. 5, 01.01.2015, p. 304-311.

Research output: Contribution to journalArticle

@article{eebeb038d738447a8364955a20616ecf,
title = "Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: Past, present, and future",
abstract = "The evidence supporting the practice of dysplasia surveillance in inflammatory bowel disease (IBD) has remained sparse, and optimal detection strategies are still lacking. These issues, added to the declining incidence of dysplasia in IBD, have led to much debate over the diagnosis and management of dysplasia. White-light endoscopy with targeted and random biopsies remains the technique of choice for most practicing gastroenterologists. However, during the past decade, a surge of literature has questioned the efficacy of this strategy. Simultaneously, chromoendoscopy has emerged as an alternative, and perhaps superior, technique that has been included in some society guidelines. Nevertheless, many issues remain unclear, such as the best way to implement chromoendoscopy into everyday practice, whether there are any outcome benefits that can be attributed to the use of chromoendoscopy, and, perhaps most importantly, how to manage dysplasia uncovered by this and other advanced techniques. In this article, we discuss the various techniques currently available for dysplasia surveillance in IBD, with a focus on chromoendoscopy. Additionally, we highlight the overarching issues of setting appropriate endpoints and individualizing the care of patients with long-standing colitis.",
keywords = "Chromoendoscopy, Crohn's disease, Dysplasia, Inflammatory bowel disease, Ulcerative colitis",
author = "Steven Naymagon and Ullman, {Thomas A.}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "304--311",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "5",

}

TY - JOUR

T1 - Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease

T2 - Past, present, and future

AU - Naymagon, Steven

AU - Ullman, Thomas A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The evidence supporting the practice of dysplasia surveillance in inflammatory bowel disease (IBD) has remained sparse, and optimal detection strategies are still lacking. These issues, added to the declining incidence of dysplasia in IBD, have led to much debate over the diagnosis and management of dysplasia. White-light endoscopy with targeted and random biopsies remains the technique of choice for most practicing gastroenterologists. However, during the past decade, a surge of literature has questioned the efficacy of this strategy. Simultaneously, chromoendoscopy has emerged as an alternative, and perhaps superior, technique that has been included in some society guidelines. Nevertheless, many issues remain unclear, such as the best way to implement chromoendoscopy into everyday practice, whether there are any outcome benefits that can be attributed to the use of chromoendoscopy, and, perhaps most importantly, how to manage dysplasia uncovered by this and other advanced techniques. In this article, we discuss the various techniques currently available for dysplasia surveillance in IBD, with a focus on chromoendoscopy. Additionally, we highlight the overarching issues of setting appropriate endpoints and individualizing the care of patients with long-standing colitis.

AB - The evidence supporting the practice of dysplasia surveillance in inflammatory bowel disease (IBD) has remained sparse, and optimal detection strategies are still lacking. These issues, added to the declining incidence of dysplasia in IBD, have led to much debate over the diagnosis and management of dysplasia. White-light endoscopy with targeted and random biopsies remains the technique of choice for most practicing gastroenterologists. However, during the past decade, a surge of literature has questioned the efficacy of this strategy. Simultaneously, chromoendoscopy has emerged as an alternative, and perhaps superior, technique that has been included in some society guidelines. Nevertheless, many issues remain unclear, such as the best way to implement chromoendoscopy into everyday practice, whether there are any outcome benefits that can be attributed to the use of chromoendoscopy, and, perhaps most importantly, how to manage dysplasia uncovered by this and other advanced techniques. In this article, we discuss the various techniques currently available for dysplasia surveillance in IBD, with a focus on chromoendoscopy. Additionally, we highlight the overarching issues of setting appropriate endpoints and individualizing the care of patients with long-standing colitis.

KW - Chromoendoscopy

KW - Crohn's disease

KW - Dysplasia

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84929402552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929402552&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84929402552

VL - 11

SP - 304

EP - 311

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 5

ER -